All the day’s economic and financial news, as relief over the French elections pushes shares higher Latest: World markets hit record highs Markets expect Macron to become next French president European markets add to Monday’s gains UK government deficit falls Joris Luyendijk: The doom-mongers got it wrong LIVE Updated <!–[if IE 9]><![endif]–><!–[if IE 9]><![endif]–> The headquarters of the Pan-European stock exchange Euronext in Paris. Photograph: Eric Piermont/AFP/Getty Images Key events Show 4.39am EDT04:39 UK deficit
Jean Sinzdak could see right away that this year would be different for women in politics. For the first time in her 12 years of running a seminar for women interested in public office, she had to start a waitlist. Registrations for the “Ready to Run” program, run by Rutgers University’s Center for American Women and Politics (CAWP), began pouring in after the presidential election. Whether it was Hillary Clinton’s loss or Donald Trump’s victory
Kasich should be pressed on what he would scrap to get a balanced budget. By ALBERT HUNT, Bloomberg View John Kasich is a lame-duck governor of Ohio, and his Republican Party is the Trumpist antithesis of the inclusive politics he preaches. But he isn’t going away. This week, the unsuccessful presidential primary candidate has a new book coming out that reprises his 2016 campaign themes, “Two Paths: America Divided or United.” The 64-year-old Kasich presents
John Kasich is a lame-duck governor of Ohio, and his Republican Party is the Trumpist antithesis of the inclusive politics he preaches. But he isn’t going away. This week, the unsuccessful presidential primary candidate has a new book coming out that reprises his 2016 campaign themes, “Two Paths: America Divided or United.” He’ll be on a national-network television interview this weekend, and Monday night will be featured in a CNN town hall in New York.
Chris Collins put millions into a drug maker seeking FDA approval. Then he wrote legislation speeding drug approval. Meanwhile, his kids, staff, donors, and fellow Republicans chipped in. When an Australian pharmaceutical company sought to raise money with the goal of entering the U.S. drug market, Rep. Chris Collins pitched in. The Republican congressman purchased $2.2 million worth of stock in Innate Immunotherapeutics as part of its initial public offering in late 2013, according to
The state affiliate of the National Rifle Assn. on Monday filed the first in a series of planned court challenges opposing sweeping new gun control laws approved in California in the wake of the San Bernardino terror attacks. The flurry of legal action comes as Neil Gorsuch, President Trump’s choice for the Supreme Court, takes his seat, returning a conservative majority to the nation’s highest court. And as the Republican administration begins appointing additional judges
Illustration: Michael Hogue / TAC In the latest issue of The American Conservative, editor Scott McConnell presents a well-considered and superlatively researched article on why France, and perhaps no longer the U.S., is at “the epicenter of today’s fearsome battle between Western elites bent on protecting and expanding the well-entrenched policy of mass immigration and those who see this spreading influx as the ultimate threat to the West’s cultural heritage, not to say its internal